Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board
- Written by PR Newswire
 |
Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company's next phase of growth
Bambusa also forms a Scientific Advisory Board of globally recognized leaders in biopharma, dermatology, and respiratory medicine to guide its immunology and inflammation pipeline
BOSTON, July 15, 2026 /PRNewswire/ --...
